Praxis precision medicines to present at 2021 wedbush pacgrow healthcare conference

Cambridge, mass., aug. 02, 2021 (globe newswire) -- praxis precision medicines, inc. (nasdaq: prax), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (cns) disorders characterized by neuronal imbalance, today announced that management will participate in a fireside chat at the 2021 wedbush pacgrow healthcare virtual conference on tuesday, august 10, 2021 at 9:10 a.m. et.
PRAX Ratings Summary
PRAX Quant Ranking